Development And Evaluation of Carvedilol SR Tablet

CHF 68.75
Auf Lager
SKU
OV9O2CU5244
Stock 1 Verfügbar
Geliefert zwischen Mi., 26.11.2025 und Do., 27.11.2025

Details

Matrix tablets containing carvedilol phosphate were prepared using 27 formulations in three batch series where different ratios of K4M CR and K15M CR were used as release retarding agents. Avicel PH 101, Starch 1500 and Lactose monohydrate were used as diluents in the formulation of three batches. The data were subjected to different models in order to evaluate their release kinetics and mechanisms. Tablets in case of all formulations showed more than 50% of drug release in 12 h when Methocel K4M CR and K15M CR constituted 18% and 15% of the matrix respectively. It was found that Avicel PH 101 decreases while Starch 1500 and Lactose monohydrate increases drug release.

Autorentext

Shimul Halder,M. Pharm, lecturer, Department of Pharmaceutical Technology,Faculty of Pharmacy,University of Dhaka,Bangladesh.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Autor Shimul Halder , Madhabi Lata Shuma , Abu Shara Shamsur Rouf
    • Titel Development And Evaluation of Carvedilol SR Tablet
    • Veröffentlichung 22.09.2011
    • ISBN 3846511250
    • Format Kartonierter Einband
    • EAN 9783846511251
    • Jahr 2011
    • Größe H220mm x B150mm x T10mm
    • Untertitel Formulation Development
    • Gewicht 233g
    • Genre Medizin
    • Anzahl Seiten 144
    • Herausgeber LAP LAMBERT Academic Publishing
    • GTIN 09783846511251

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470